A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib in Patients With Metastatic Castration-Resistant Prostate Cancer
Phase of Trial: Phase II
Latest Information Update: 04 Dec 2019
Price : $35 *
At a glance
- Drugs Abemaciclib (Primary) ; Abiraterone acetate; Prednisone
- Indications Adenocarcinoma; Prostate cancer
- Focus Therapeutic Use
- Sponsors Eli Lilly and Company
- 26 May 2019 This trial has been completed in England according to European Clinical Trials Database record.
- 03 Dec 2018 Status changed from not yet recruiting to recruiting.
- 19 Nov 2018 Planned initiation date changed from 17 Oct 2018 to 26 Nov 2018.